Skip to main content

Johns Hopkins Microarray Core Facility Licenses InforMax s GenoMax

NEW YORK, March 26 - InforMax said on Tuesday it has licensed its GenoMax informatics platform to Johns Hopkins University School of Medicine Microarray Core Facility.
 
Financial terms of the agreement were not disclosed.

 

Two weeks ago, InforMax named Andrew Whiteley president, chairman, and CEO. Whiteley takes over from Alex Titomirov, the company's founder, who is resigning from the company immediately, InforMax said in a statement.

Whiteley, who came to InforMax from Amersham, said he plans immediately to bolster his company's marketing efforts.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.